19.10.2016 • NewsElaine BurridgeHaldor TopsoeCB&I

CB&I and Haldor Topsoe Partner on Syngas

US engineering contractor CB&I has signed an agreement for a long-term alliance on syngas with Danish catalysis and process technology company Haldor Topsoe. Under the deal, CB&I will promote Haldor Topsoe’s syngas-based technologies, which the US-firm said complements its existing portfolio. The alliance adds eight Haldor Topsoe process technologies to CB&I’s current offering of more than 90 technologies and 3,500 patents, while also allowing the US firm to capitalize on the Lyngby-headquartered company’s expertise in engineering, procurement and construction (EPC).

CB&I will also work with Haldor Topsoe on providing EPC services to plants in North America. Patrick Mullen, CB&I’s chief operating officer, said the alliance gives it additional competitive offerings to the industry, adding that the two companies have a long history of technology collaboration. Both companies are working together on a refinery upgrade for Pertamina in Indonesia. The project at Pertamina’s Unit V refinery in Balikpapan, East Kalimantan, will use CB&I’s CDAlky advanced sulfuric acid alkylation process and Haldor Topsoe’s wet gas sulfuric acid technology.

CDAlky is an environmentally friendly alternative route to obtain high-octane premium gasoline that eliminates the need for human contact with sulfuric acid.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.